Tags: Drug.

Robatumumab (proposed INN) is a monoclonal antibody and an antineoplastic by Schering-Plough. It binds to CD221 the insulin-like growth factor 1 receptor.

ATC prefix
none
CAS number
934235-44-6
FDA UNII code
V983921H3B

Loading...

This page contains content from the copyrighted Wikipedia article "Robatumumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.